Primary cutaneous T-cell lymphomaNews & Research
12 curated articles for Primary cutaneous T-cell lymphoma — FDA updates, peer-reviewed research, clinical-trial milestones, and sponsor press releases. Sorted newest-first.
- Journal of clinical research in pediatric endocrinology May 22, 2026
A Rare Coexistence of Turner Syndrome and Mycosis Fungoides: A Case Report.
Turner syndrome (TS) is the most common sex chromosome abnormality among females, characterized by short stature, hypergonadotropic hypogonadism, congenital heart anomalies, and an increased risk of autoimmune diseases. Although TS does not typically increase the absolute risk of malignancy, specifi...
Why it matters: Recent peer-reviewed research on Primary cutaneous T-cell lymphoma that may be relevant for patients and caregivers.
- Medicine May 12, 2026
Development and validation of a prognostic nomogram for overall survival in patients with primary cutaneous T-cell lymphoma: A SEER-based study.
The prognosis of cutaneous T-cell lymphoma (CTCL) remains heterogeneous, and clinically applicable prognostic tools are needed. Using population-based Surveillance, Epidemiology, and End Results (SEER) data (2000-2019), we analyzed incidence trends and developed a prognostic nomogram for overall sur...
Why it matters: Recent peer-reviewed research on Primary cutaneous T-cell lymphoma that may be relevant for patients and caregivers.
- Medicina (Kaunas, Lithuania) May 4, 2026
Mimicry in Cutaneous Malignancy-Rare Forms of Mycosis Fungoides as Diagnostic Pitfalls: A Narrative Review.
Mycosis fungoides (MF) is a rare primary cutaneous T-cell lymphoma (pCTCL) that generally has an indolent course with a favorable prognosis. However, numerous clinical variants have been described that differ substantially from classic Alibert-Bazin MF, resulting in altered prognosis, treatment resp...
Why it matters: Recent peer-reviewed research on Primary cutaneous T-cell lymphoma that may be relevant for patients and caregivers.
- Transplant immunology May 2, 2026
Chidamide maintenance after allogeneic hematopoietic stem cell transplantation in mycosis fungoides: A case report.
Primary cutaneous T-cell lymphoma (CTCL) comprises a group of rare, aggressive non-Hodgkin lymphomas, of which mycosis fungoides (MF) and Sézary syndrome are the most common subtypes. In the absence of a universally accepted standard of care for advanced stages, allogeneic hematopoietic stem ce...
Why it matters: Recent peer-reviewed research on Primary cutaneous T-cell lymphoma that may be relevant for patients and caregivers.
- Blood reviews Apr 29, 2026
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): A practical compartment-based review.
Primary cutaneous lymphomas are a heterogeneous group of lymphoid neoplasms with predominant skin involvement, among which mycosis fungoides (MF) and Sézary syndrome (SS) are the most frequent and clinically challenging entities. This narrative review provides a multidisciplinary, compartment-o...
Why it matters: Recent peer-reviewed research on Primary cutaneous T-cell lymphoma that may be relevant for patients and caregivers.
- Cureus Apr 13, 2026
Moderate-Dose Local Radiotherapy in Symptomatic CD30-Positive, Anaplastic Lymphoma Kinase (ALK)-Negative Primary Cutaneous T-cell Lymphoma.
Primary cutaneous anaplastic CD30-positive (+) T-cell lymphoma is a rare variant of primary cutaneous lymphoma characterized by proliferation of large T lymphocytes with strong CD30 expression and no anaplastic lymphoma kinase (ALK) expression. It typically presents as rapidly growing nodules or tum...
Why it matters: Recent peer-reviewed research on Primary cutaneous T-cell lymphoma that may be relevant for patients and caregivers.
- The American Journal of dermatopathology Apr 10, 2026
Hypopigmented CD8+ Mycosis Fungoides in Sri Lanka: Clinicopathologic Evidence for an Indolent Variant.
Mycosis fungoides (MF) is the most common primary cutaneous T-cell lymphoma and typically presents with erythematous or scaly patches in older adults with a CD4+ immunophenotype. In Sri Lanka, however, a hypopigmented variant with CD8+ predominance and an apparently indolent clinical course is frequ...
Why it matters: Recent peer-reviewed research on Primary cutaneous T-cell lymphoma that may be relevant for patients and caregivers.
- Oncology and therapy Apr 1, 2026
Results from a Pilot Study of HyBryte™ (Topical Synthetic Hypericin) Versus Valchlor ® (Mechlorethamine) in the Treatment of CTCL.
Mycosis fungoides (MF) is the most common type of primary cutaneous T-cell lymphoma (CTCL), a malignant and chronic skin disease. Early-stage MF has a generally favorable prognosis, but effective and well-tolerated skin-directed therapies are crucial for management. HyBryte™ is a photodynamic...
Why it matters: Recent peer-reviewed research on Primary cutaneous T-cell lymphoma that may be relevant for patients and caregivers.
- Experimental dermatology Mar 27, 2026
Molecular Markers Distinguishing Early-Stage Mycosis Fungoides From Atopic Dermatitis Skin Lesions.
Mycosis fungoides (MF) is the most common type of primary cutaneous T-cell lymphoma, a disease characterized by malignant T cells that home to the skin. In early stages, clinical presentation is often indistinguishable from benign chronic inflammatory skin diseases such as atopic dermatitis (AD), po...
Why it matters: Recent peer-reviewed research on Primary cutaneous T-cell lymphoma that may be relevant for patients and caregivers.
- Blood neoplasia Mar 12, 2026
T-cell receptor gamma (TRG) diversity predicts peripheral blood involvement in primary cutaneous T-cell lymphoma.
T-cell receptor gamma (TRG) diversity predicts peripheral blood involvement in primary cutaneous T-cell lymphoma.
Why it matters: Recent peer-reviewed research on Primary cutaneous T-cell lymphoma that may be relevant for patients and caregivers.
- Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology Feb 7, 2026
Radiotherapy dose-response of mycosis fungoides with large cell transformation.
Mycosis fungoides (MF) is the most prevalent subtype of primary cutaneous T-cell lymphoma. Large cell transformation of MF (LCTMF) is rare and confers a poor prognosis. Radiotherapy (RT) is an effective local treatment for LCTMF; however, dose-response data are limited. Eligibility for this retrospe...
Why it matters: Recent peer-reviewed research on Primary cutaneous T-cell lymphoma that may be relevant for patients and caregivers.
- Journal of the American Academy of Dermatology Jan 23, 2026
Clinical presentation and survival outcomes of primary cutaneous T-cell lymphoma among disaggregated Asian American, Native Hawaiian, and Pacific Islander populations.
Clinical presentation and survival outcomes of primary cutaneous T-cell lymphoma among disaggregated Asian American, Native Hawaiian, and Pacific Islander populations.
Why it matters: Recent peer-reviewed research on Primary cutaneous T-cell lymphoma that may be relevant for patients and caregivers.
More on Primary cutaneous T-cell lymphoma
Articles aggregated from peer-reviewed journals (PubMed), sponsor press releases, SEC 8-K filings, and FDA announcements. Original-source links are preserved on each article page. Editorial tags (Breaking / Notable / Update) reflect UniteRare's curation-time priority assessment.